Cynosure Lutronic has introduced its next-generation monopolar RF platform, XERF, to the European market, capitalizing on rising patient demand for non-invasive skin tightening. The launch positions Cynosure against established competitors like InMode's Morpheus8 and Lumenis platforms in a segment where RF microneedling and radiofrequency have become standard offerings in most medspas.
Devices & Tech
Cynosure Launches XERF Monopolar RF in Europe — Next-Gen Skin Tightening Enters Crowded Market
The device maker expands its RF footprint as non-invasive tightening demand accelerates across the continent.
Monopolar RF adoption is maturing globally, typically preceding aggressive pricing in domestic markets.
Monopolar RF—which delivers energy deeper into dermis and subcutaneous tissue than fractional RF—remains a high-margin procedure for practices that own the hardware. Cynosure's entry into Europe with XERF reflects the company's strategy to compete on technology differentiation rather than price alone. For U.S. practice owners, the European launch signals that monopolar RF adoption is maturing globally, which typically precedes aggressive pricing and rebate competition in domestic markets. Practices already running RF should monitor whether Cynosure's European momentum translates to financing incentives or loyalty rebates in North America.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.